Preoperative single-dose intravenous dexamethasone during ambulatory surgery: update around the benefit versus risk.
Summary of "Preoperative single-dose intravenous dexamethasone during ambulatory surgery: update around the benefit versus risk."
Pain, emesis, and fatigue are not uncommon symptoms after ambulatory surgery having impact on patients' satisfaction with quality of care. Multimodal management of postoperative pain and nausea and vomiting has become standard of care. RECENT
There is a growing body of evidence for the beneficial effects from preoperative single-dose intravenous (i.v.) glucocorticoids for reducing pain, emesis, and fatigue, thereby improving the recovery process and patient satisfaction. Side-effects are infrequently reported.
The benefits versus risk associated to single preoperative i.v. dose of dexamethasone seem positive based on current evidence facilitating the recovery reducing pain and postoperative nausea and vomiting.
Department of Anesthesia & Intensive Care, Institution for Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
This article was published in the following journal.
Name: Current opinion in anaesthesiology
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20847689
- DOI: http://dx.doi.org/10.1097/ACO.0b013e32833ff302
This article addresses the effect of 2 different concentrations (4 and 12 mg) of dexamethasone to control pain, swelling, and trismus after third molar surgery. A clinical study was conducted with 27 ...
To determine the effects of intravenous and perineural dexamethasone on the duration of interscalene brachial plexus block (ISB) with ropivacaine in patients undergoing arthroscopic shoulder surgery.
Establish a protocol of management of acute appendicitis (AA) in ambulatory surgery (AmbSurg) on the basis of preoperative criteria.
Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-...
A few studies are available actually comparing the clinical efficacy of intravenous acetaminophen with other medications such as dexamethasone to inhibit postoperative adverse events in children.
The objective of the study is to examine the effect of the addition of intravenous dexamethasone 1.5 hours prior to induction of anesthesia on the post-operative opioid consumption, pain s...
The purpose of the study is to determine the opiate sparing effects of intravenously administered dexamethasone in outpatient knee surgery. Dexamethasone is a glucocorticoid with well kno...
The question of a possible hyperglycemic effect from single-dose dexamethasone is an important issue for clinicians managing patients in the intraoperative and postoperative periods. Rece...
Dexamethasone has been reported to reduce postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy (LC). However, its effects on other surgical outcomes such as pain and...
The purpose of this study is to determine if a single intravenous (IV) dose of palonosetron 0.25 mg plus a single IV dose of dexamethasone 8 mg is effective to prevent nausea and vomiting ...
Medical and Biotech [MESH] Definitions
Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed)
The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population.
Mice selectively bred for hypersusceptibility to two-stage chemical skin carcinogenesis. They are also hypersusceptible to UV radiation tumorigenesis with single high-dose, but not chronic low-dose, exposures. SENCAR (SENsitive to CARcinogenesis) mice are used in research as an animal model for tumor production.
Surgery performed on an outpatient basis. It may be hospital-based or performed in an office or surgicenter.
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.